Tag: Bone marrow transplant

Following an allogeneic bone marrow transplant (BMT), nearly all patients require immunosuppressive drugs to prevent complications. **How long do you take immunosuppressants after a bone marrow transplant** is not a simple question, as the timeline is highly individualized and dependent on factors like the type of transplant and the risk of graft-versus-host disease (GVHD).

Over 40% of patients receiving certain strong chemotherapy regimens can develop febrile neutropenia, a serious condition that filgrastim helps prevent. This article explains what is the therapeutic use of filgrastim and its critical role in boosting the body's white blood cell count to fight infection.